HIGHLANDS RANCH, Colo., Oct. 22, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for patients suffering from mild to moderate obstructive sleep apnea (OSA) and snoring in adults, today announced that Vivos’ Chairman and Chief Executive Officer, Kirk Huntsman, and Vivos’ Chief Financial Officer, Brad Amman, will be presenting at the online Benzinga Global Small Cap Conference at 12:15 pm ET on Wednesday, October 27, 2021. The Benzinga Global Small Cap Conference will be taking place from October 27-28, 2021.
Vivos Therapeutics to Participate at the Benzinga Global Small Cap Conference
Provided Content: Content provided by Globe Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.
